| Literature DB >> 35703612 |
Fábio Lourenço Romano1, Cássio Edward Sverzut2, Alexandre Elias Trivellato2, Maria Conceição Pereira Saraiva3, Tung Tahan Nguyen4.
Abstract
INTRODUCTION: Surgically Assisted Rapid Palatal Expansion (SARPE) promote maxillary expansion in skeletally mature patients. This technique is effective; however, some side effects are still unknown.Entities:
Mesh:
Year: 2022 PMID: 35703612 PMCID: PMC9191858 DOI: 10.1590/2177-6709.27.2.e2219299.oar
Source DB: PubMed Journal: Dental Press J Orthod ISSN: 2176-9451
Figure 1:Study design ( Inclusion and exclusion criteria ).
Figure 2:A) Hyrax expander with bands on the first molars and first premolars. Patients were instructed to perform two turns in the morning and two turns at night. B) Overcorrection of maxillomandibular transverse relationship.
Figure 3:Conventional bilateral LeFort I osteotomy and midline separation: A) right side; B) left side; C) anterior view.
Figure 4:CBCT coronal slice showing dehiscence (A) and fenestration (B).
Fenestration and dehiscence per tooth at each time point.
| T1 | T2 | T3 | p* | |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||
| Second molar | ||||
| No defect | 105 (98.2) | 101 (94.4) | 97 (90.7) | 0.2263 |
| Fenestration | 1 (0.9) | 3 (2.8) | 5 (4.6) | |
| Dehiscence | 1 (0.9) | 3 (2.8) | 5 (4.6) | |
| First molar | ||||
| No defect | 70 (60.3) | 35 (30.2) | 18(15.2) | < 0.0001 |
| Fenestration | 21 (18.1) | 17 (14.7) | 4 (3.5) | |
| Dehiscence | 25 (21.6) | 64 (55.2) | 94 (81.0) | |
| Second premolar | ||||
| No defect | 54 (93.0) | 43 (74.1) | 38 (65.2) | 0.0054 |
| Fenestration | 2 (3.5) | 4 (6.9) | 4 (6.9) | |
| Dehiscence | 2(3.5) | 11 (19.0) | 16 (27.6) | |
| First premolar | ||||
| No defect | 38 (73.1) | 19 (36.5) | 8 (15.4) | < 0.0001 |
| Fenestration | 6 (11.5) | 6 (11.5) | 2 (3.8) | |
| Dehiscence | 8 (15.4) | 27 (51.9) | 42 (80.8) | |
| Canine | ||||
| No defect | 56 (96.5) | 51 (87.9) | 49 (84.5) | < 0.0001 |
| Fenestration | 0 (0.0) | 0 (0.0) | 1 (1.7) | |
| Dehiscence | 2 (3.5) | 7 (12.1) | 8 (13.8) | |
*p-value for Wald chi-square of association between time and defects, taking into consideration dependence of observation within individual and tooth.
Comparison of the probability for the increase in the number of dehiscence between the study times, sides, teeth, surfaces, sex and age.
| RR crude | 95% CI | p | RR adjusted | 95% CI* | p† | |
|---|---|---|---|---|---|---|
| Time | ||||||
| T1 | 1 | 1 | < 0.0001 | |||
| T2 | 2.95 | 2.31 - 3.77 | < 0.0001 | 2.95 | 2.31 - 3.77 | |
| T3 | 4.34 | 3.35 - 5.63 | 4.34 | 3.35 - 5.63 | ||
| Side | ||||||
| Right | 1 | 0.4356 | 1 | 0.1353 | ||
| Left | 1.13 | 0.83 - 1.54 | 1.16 | 0.94 - 1.41 | ||
| Teeth | ||||||
| Second molar | 0.17 | 0.05 - 0.55 | 0.14 | 0.04 - 0.44 | < 0.0001 | |
| First molar | 3.16 | 1.99 - 5.00 | < 0.0001 | 2.6 | 1.61 - 4.19 | |
| Second premolar (ref) | 1 | 1 | 1 | 1 | ||
| First premolar | 2.96 | 1.84 - 4.77 | 3.02 | 1.87 - 4.89 | ||
| Canine | 0.59 | 0.26 - 1.32 | 0.59 | 0.26 - 1.31 | ||
| Surfaces | ||||||
| Distal | 1 | 1 | ||||
| Mesial | 1.43 | 1.16 - 1.77 | 0.002 | 1.43 | 1.16 - 1.77 | 0.001 |
| Unique face | 0.73 | 0.75 - 1.44 | 1 | 1.00 - 1.00 | ||
| Sex | ||||||
| Male | 1 | 1 | 0.0684 | |||
| Female | 0.98 | 0.72 - 1.33 | 0.8931 | 0.83 | 0.67 - 1.01 | |
| Age (years) | ||||||
| ≤ 35 | 1 | 1 | 0.2487 | |||
| > 35 | 1.11 | 0.79 - 1.56 | 0.5424 | 1.26 | 0.85 - 1.89 | |
| Presence of defects at baseline | ||||||
| No defect | 1 | 0.0555 | 1 | 0.0003 | ||
| One defect | 1.23 | 0.80 - 1.89 | 0.0168(trend) | 1.06 | 0.69 - 1.63 | |
| Both defects | 1.52 | 1.08 - 2.15 | 1.58 | 1.25 - 2.01 | ||
* 95% CI = 95% confidence interval. † p-value for Wald chi-square statistics. On the left side, is the crude RR with 95% confidence Intervals; and on the right side, the adjusted RR. Each RR should be interpreted as the RR independent of the other variables in the model, even though sex, age and side were not significant in the model.
Figure 5:Fenestration (A) of the maxillary first molar (mesial root) changed, in the same patient, to dehiscence (B) after SARPE.